Review Article
Clinical and Translational Considerations for Understanding Depression and Anxiety in Patients with Inflammatory Bowel Disease
Table 1
The prevalence of depression and anxiety in various IBD cohorts.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IBD: inflammatory bowel disease; D: depression; A: anxiety; PHQ: Patient Health Questionnaire; GAD: general anxiety disorder; UK: United Kingdom; CAT-MH: Computerized Adaptive Testing for Mental Health; ICD-9: International Classification of Diseases, Ninth Revision; HADS: Hospital Anxiety and Depression Scale; PROMIS GHS: Patient-Reported Outcomes Measurement Information System Global Health Survey; WHODAS: WHO Disability Assessment Schedule; SCID: Structured Clinical Interview for Axis I Disorders; NIS: Nationwide Inpatient Sample; GHS: Global Health Scale; SF: Short Form Health Survey; K10: Kessler Psychological Distress Scale. |